genetech inc said still remains confident will able work with food and drug adminstration obtain approval its tissue plasminogen activator activase for treating heart attack victims friday advisory committee fda recommended blood clot dissolving drug not approved until additional mortality data developed genetech said will additional data and believes much not all already being developed reuter 